comparemela.com

Latest Breaking News On - Rigel pharmaceuticals company profile - Page 1 : comparemela.com

Rigel Pharmaceuticals (NASDAQ:RIGL) Issues Quarterly Earnings Results, Misses Estimates By $0 02 EPS

Rigel Pharmaceuticals (NASDAQ:RIGL) Issues Quarterly Earnings Results, Misses Estimates By $0 02 EPS
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Rigel Pharmaceuticals (NASDAQ:RIGL) Announces Quarterly Earnings Results

Rigel Pharmaceuticals (NASDAQ:RIGL) Announces Quarterly Earnings Results
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Rigel Pharmaceuticals (RIGL) Set to Announce Quarterly Earnings on Tuesday

Rigel Pharmaceuticals (RIGL) Set to Announce Quarterly Earnings on Tuesday
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

B Riley Reiterates Neutral Rating for Rigel Pharmaceuticals (NASDAQ:RIGL)

B. Riley reissued their neutral rating on shares of Rigel Pharmaceuticals (NASDAQ:RIGL – Free Report) in a report published on Wednesday morning, Benzinga reports. They currently have a $1.25 price objective on the biotechnology company’s stock. B. Riley also issued estimates for Rigel Pharmaceuticals’ Q1 2024 earnings at ($0.01) EPS, Q2 2024 earnings at ($0.04) […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.